{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:46:34Z","timestamp":1782927994306,"version":"3.54.5"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471405"],"award-info":[{"award-number":["82471405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mild cognitive impairment (MCI) is a key stage for early intervention in dementia, and its inflammatory mechanisms remain unclear. Myeloperoxidase (MPO), a key enzyme involved in inflammation and immune regulation, has not been fully studied in MCI. This multicenter longitudinal cohort study prospectively followed 133 patients with MCI for 12\u2009months. Plasma MPO, Alzheimer\u2019s disease (AD)-related biomarkers (p-Tau181, p-Tau217, glial fibrillary acidic protein , neurofilament light chain, and A\u03b242\/40), inflammatory cytokines (IL-1\u03b2, IL-6, and TNF-\u03b1), neuropsychological performance, and APOE genotype were assessed at baseline and follow-up. During follow-up, 58 patients showed cognitive deterioration and 75 remained non-deteriorated. At both baseline and the 12-month follow-up, the cognitive deterioration group showed higher MPO, IL-1\u03b2, and IL-6 levels than the non-deterioration group. Within-group longitudinal changes from baseline to follow-up were modest and were not statistically significant. Cross-sectional analyses showed that MPO was associated with IL-1\u03b2, IL-6, A\u03b242\/40, Mini-Mental State Examination (MMSE), and Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) at different assessment time points. Longitudinal delta analyses showed that changes in MPO were significantly correlated with changes in MMSE, IL-1\u03b2, and IL-6, but not with changes in ADAS-Cog or A\u03b242\/40. After adjustment for potential confounders, MPO remained an independent predictor of cognitive deterioration in MCI (OR\u2009=\u20091.018, 95% CI, 1.00-1.03, p\u2009=\u2009.015). Nomogram analysis showed that MPO was the most prominent predictor in the model. These findings suggest that elevated plasma MPO may serve as a clinically accessible prognostic biomarker for risk stratification in patients with MCI.<\/jats:p>","DOI":"10.1093\/gerona\/glag135","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:33:05Z","timestamp":1779190385000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study"],"prefix":"10.1093","volume":"81","author":[{"given":"Wenxian","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Neurology, Zhongnan Hospital of Wuhan University , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Shan","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heya","family":"Luan","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7380-7451","authenticated-orcid":false,"given":"Cuibai","family":"Wei","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases , Beijing,","place":["China"]},{"name":"Jinan Hospital of Xuanwu Hospital, Shandong First Medical University , Jinan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2026070112573545600_glag135-B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"2026070112573545600_glag135-B2","doi-asserted-by":"publisher","first-page":"101158","DOI":"10.1016\/j.lanwpc.2024.101158","article-title":"Projection for dementia burden in China to 2050: a macro-simulation study by scenarios of dementia incidence trends","volume":"50","author":"Liu","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026070112573545600_glag135-B3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/wnl.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"2026070112573545600_glag135-B4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2020.8030","article-title":"The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease","volume":"32","author":"Davies","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"2026070112573545600_glag135-B5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/ars.2019.7971","article-title":"Myeloperoxidase as a multifaceted target for cardiovascular protection","volume":"32","author":"Ramachandra","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"2026070112573545600_glag135-B6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/circulationaha.123.067931","article-title":"Novel mouse model of myocardial infarction, plaque rupture, and stroke shows improved survival with myeloperoxidase inhibition","volume":"150","author":"Shamsuzzaman","year":"2024","journal-title":"Circulation"},{"key":"2026070112573545600_glag135-B7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00441-017-2626-8","article-title":"Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson\u2019s and Alzheimer\u2019s disease","volume":"369","author":"Gellhaar","year":"2017","journal-title":"Cell Tissue Res"},{"key":"2026070112573545600_glag135-B8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3233\/jad-131469","article-title":"Increased myeloperoxidase plasma levels in patients with Alzheimer\u2019s disease","volume":"39","author":"Tzikas","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"2026070112573545600_glag135-B9","doi-asserted-by":"publisher","first-page":"107870","DOI":"10.18632\/oncotarget.22330","article-title":"The association of MPO gene promoter polymorphisms with Alzheimer\u2019s disease risk in Chinese Han population","volume":"8","author":"Ji","year":"2017","journal-title":"Oncotarget"},{"key":"2026070112573545600_glag135-B10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3389\/fnins.2019.00990","article-title":"Myeloperoxidase deficiency inhibits cognitive decline in the 5XFAD Mouse Model of Alzheimer\u2019s disease","volume":"13","author":"Volkman","year":"2019","journal-title":"Front Neurosci"},{"key":"2026070112573545600_glag135-B11","doi-asserted-by":"publisher","first-page":"2456282","DOI":"10.1080\/14756366.2025.2456282","article-title":"Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer\u2019s disease","volume":"40","author":"Rivera Antonio","year":"2025","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2026070112573545600_glag135-B12","doi-asserted-by":"publisher","first-page":"e082404","DOI":"10.1136\/bmjopen-2023-082404","article-title":"Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)","volume":"14","author":"Wang","year":"2024","journal-title":"BMJ Open"},{"key":"2026070112573545600_glag135-B13","first-page":"231","article-title":"The cognitive subscale of Alzheimer\u2019s Disease Assessment Scale, Chinese version in staging of Alzheimer disease","volume":"18","author":"Wang","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2026070112573545600_glag135-B14","doi-asserted-by":"publisher","first-page":"CD010783","DOI":"10.1002\/14651858.CD010783.pub2","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI)","volume":"2015","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070112573545600_glag135-B15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"2026070112573545600_glag135-B16","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"2026070112573545600_glag135-B17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2174\/1567205011666140317101419","article-title":"Understanding the complexities of functional ability in Alzheimer\u2019s disease: more than just basic and instrumental factors","volume":"11","author":"Kahle-Wrobleski","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"2026070112573545600_glag135-B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archpsyc.1994.03950010051007","article-title":"WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings","volume":"51","author":"Maj","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"2026070112573545600_glag135-B19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X","article-title":"The Trail Making Test in neuropsychological diagnosis","volume":"28","author":"Gordon","year":"1972","journal-title":"J Clin Psychol"},{"key":"2026070112573545600_glag135-B20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/00207459008985956","article-title":"Factor analysis of the mainland Chinese version of the Wechsler Adult Intelligence Scale (WAIS-RC) in a brain-damaged sample","volume":"55","author":"Dai","year":"1990","journal-title":"Int J Neurosci"},{"key":"2026070112573545600_glag135-B21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2174\/1567205019666220404104854","article-title":"Is the Alzheimer\u2019s disease assessment scale-cognitive subscale useful in screening for mild cognitive impairment and Alzheimer\u2019s disease? A systematic review","volume":"19","author":"Park","year":"2022","journal-title":"Curr Alzheimer Res"},{"key":"2026070112573545600_glag135-B22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13760-021-01780-5","article-title":"Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"122","author":"Ulbl","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"2026070112573545600_glag135-B23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"2026070112573545600_glag135-B24","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010132","article-title":"The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress","volume":"13","author":"Lin","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"2026070112573545600_glag135-B25","doi-asserted-by":"publisher","first-page":"828174","DOI":"10.3389\/fmed.2022.828174","article-title":"Correlation analysis of plasma myeloperoxidase level with global registry of acute coronary events score and prognosis in patients with acute Non-ST-Segment elevation myocardial infarction","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2026070112573545600_glag135-B26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/ejhf.2977","article-title":"Rationale and design of ENDEAVOR: a sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction","volume":"25","author":"Lund","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026070112573545600_glag135-B27","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/circulationaha.125.074085","article-title":"MYSTERY-HF: myeloperoxidase inhibition in patients with heart failure and reduced ejection fraction: a phase ii randomized controlled trial","volume":"151","author":"Braumann","year":"2025","journal-title":"Circulation"},{"key":"2026070112573545600_glag135-B28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fimmu.2015.00463","article-title":"Pathologic and protective roles for microglial subsets and bone marrow- and blood-derived myeloid cells in central nervous system inflammation","volume":"6","author":"Wlodarczyk","year":"2015","journal-title":"Front Immunol"},{"key":"2026070112573545600_glag135-B29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12974-023-02991-8","article-title":"Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in cerebral ischemia-reperfusion injury","volume":"21","author":"Chen","year":"2024","journal-title":"J Neuroinflammation"},{"key":"2026070112573545600_glag135-B30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.neubiorev.2016.06.031","article-title":"Myeloperoxidase: bridging the gap in neurodegeneration","volume":"68","author":"Ray","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"2026070112573545600_glag135-B31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1046\/j.1440-1711.2001.01020.x","article-title":"Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited","volume":"79","author":"Lefkowitz","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"2026070112573545600_glag135-B32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.it.2009.06.006","article-title":"Neutrophil granule proteins tune monocytic cell function","volume":"30","author":"Soehnlein","year":"2009","journal-title":"Trends Immunol"},{"key":"2026070112573545600_glag135-B33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-021-00451-6","article-title":"A blood-based diagnostic test incorporating plasma A\u03b242\/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis","volume":"16","author":"West","year":"2021","journal-title":"Mol Neurodegener"},{"key":"2026070112573545600_glag135-B34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-023-01296-5","article-title":"Performance of plasma A\u03b242\/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status","volume":"15","author":"Bun","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"2026070112573545600_glag135-B35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-022-01347-2","article-title":"Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer\u2019s disease","volume":"10","author":"Smyth","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2026070112573545600_glag135-B36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer\u2019s disease","volume":"90","author":"Green","year":"2004","journal-title":"J Neurochem"},{"key":"2026070112573545600_glag135-B37","doi-asserted-by":"publisher","first-page":"107711","DOI":"10.1016\/j.pharmthera.2020.107711","article-title":"Myeloperoxidase: a versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease","volume":"221","author":"Maiocchi","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2026070112573545600_glag135-B38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41531-025-00941-0","article-title":"Association between serum myeloperoxidase enzyme activity and Parkinson\u2019s disease status","volume":"11","author":"Espejo","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"key":"2026070112573545600_glag135-B39","doi-asserted-by":"publisher","first-page":"e70109","DOI":"10.1111\/cns.70109","article-title":"Targeting myeloperoxidase to reduce neuroinflammation in X-Linked dystonia parkinsonism","volume":"30","author":"Petrozziello","year":"2024","journal-title":"CNS Neurosci Ther"}],"container-title":["The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glag135\/68370796\/glag135.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/7\/glag135\/68370796\/glag135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/7\/glag135\/68370796\/glag135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:00:44Z","timestamp":1782925244000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/doi\/10.1093\/gerona\/glag135\/8690938"}},"subtitle":[],"editor":[{"given":"Gustavo","family":"Duque","sequence":"additional","affiliation":[{"name":"(Biological Sciences Section)"}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glag135","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,22]]},"article-number":"glag135"}}